Robert Martin Emanuele founded Visgenx, Inc. Presently, he occupies the position of President & Chief Executive Officer at Liferaft Biosciences, Inc., and Chief Operating Officer & Director at Visgenx, Inc. Dr. Emanuele is also on the board of Artelo Biosciences, Inc.
In the past Dr. Emanuele held the position of Vice President-Research & Business Development at CytRx Corp., Senior Vice President-Business Development at Kémia, Inc., Chief Business Officer of Virobay, Inc., Vice President-Pharmaceutical Strategy at DaVita, Inc., Senior Vice President-Development at Savara, Inc. President at Synthrx, Inc. and Senior Vice President-Development at Mast Therapeutics, Inc. (both are subsidiaries of Savara, Inc.), Clinical Research Scientist at Dupont Critical Care, Inc., Vice President-Licensing & Business Development at Avanir Pharmaceuticals, Inc. and Principal at E.I. du Pont de Nemours & Co.
Dr. Emanuele received an undergraduate degree from Colorado State University, an MBA from The University of Colorado and a doctorate from Stritch School of Medicine.